These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 35794701)

  • 21. Evolution and rapid spread of a reassortant A(H3N2) virus that predominated the 2017-2018 influenza season.
    Potter BI; Kondor R; Hadfield J; Huddleston J; Barnes J; Rowe T; Guo L; Xu X; Neher RA; Bedford T; Wentworth DE
    Virus Evol; 2019 Jul; 5(2):vez046. PubMed ID: 33282337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-genome sequencing reveals origin and evolution of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018.
    Zhao XN; Zhang HJ; Li D; Zhou JN; Chen YY; Sun YH; Adeola AC; Fu XQ; Shao Y; Zhang ML
    PLoS One; 2020; 15(6):e0234869. PubMed ID: 32579578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.
    Rose A; Kissling E; Emborg HD; Larrauri A; McMenamin J; Pozo F; Trebbien R; Mazagatos C; Whitaker H; Valenciano M;
    Euro Surveill; 2020 Mar; 25(10):. PubMed ID: 32183932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-circulation of influenza A(H1N1), A(H3N2), B(Yamagata) and B(Victoria) during the 2017-2018 influenza season in Zhejiang Province, China.
    Mao H; Sun Y; Chen Y; Lou X; Yu Z; Wang X; Ding Z; Cheng W; Zhang D; Zhang Y; Jiang J
    Epidemiol Infect; 2020 Feb; 148():e296. PubMed ID: 32054554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.
    Takashita E; Daniels RS; Fujisaki S; Gregory V; Gubareva LV; Huang W; Hurt AC; Lackenby A; Nguyen HT; Pereyaslov D; Roe M; Samaan M; Subbarao K; Tse H; Wang D; Yen HL; Zhang W; Meijer A
    Antiviral Res; 2020 Mar; 175():104718. PubMed ID: 32004620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter- Versus Intra-Host Sequence Diversity of pH1N1 and Associated Clinical Outcomes.
    Al Khatib HA; Al Maslamani MA; Coyle PV; Thompson IR; Farag EA; Al Thani AA; Yassine HM
    Microorganisms; 2020 Jan; 8(1):. PubMed ID: 31963512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza.
    Van Poelvoorde LAE; Saelens X; Thomas I; Roosens NH
    Trends Biotechnol; 2020 Apr; 38(4):360-367. PubMed ID: 31810633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.
    Wan H; Gao J; Yang H; Yang S; Harvey R; Chen YQ; Zheng NY; Chang J; Carney PJ; Li X; Plant E; Jiang L; Couzens L; Wang C; Strohmeier S; Wu WW; Shen RF; Krammer F; Cipollo JF; Wilson PC; Stevens J; Wan XF; Eichelberger MC; Ye Z
    Nat Microbiol; 2019 Dec; 4(12):2216-2225. PubMed ID: 31406333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic characterization of hemagglutinin (HA) gene of influenza A viruses circulating in Southwest India during 2017 season.
    Jagadesh A; Krishnan A; Nair S; Sivadas S; Arunkumar G
    Virus Genes; 2019 Aug; 55(4):458-464. PubMed ID: 31129786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory syncytial virus, human metapneumovirus, and influenza virus infection in Bangkok, 2016-2017.
    Thongpan I; Suntronwong N; Vichaiwattana P; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PeerJ; 2019; 7():e6748. PubMed ID: 30997293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season.
    Korsun NS; Angelova SG; Trifonova IT; Georgieva IL; Tzotcheva IS; Mileva SD; Voleva SE; Kurchatova AM; Perenovska PI
    Epidemiol Infect; 2019 Jan; 147():e76. PubMed ID: 30869003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequencing Framework for the Sensitive Detection and Precise Mapping of Defective Interfering Particle-Associated Deletions across Influenza A and B Viruses.
    Alnaji FG; Holmes JR; Rendon G; Vera JC; Fields CJ; Martin BE; Brooke CB
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
    Doyle JD; Chung JR; Kim SS; Gaglani M; Raiyani C; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Foust A; Sessions W; Berman L; Garten RJ; Barnes JR; Wentworth DE; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(6):135-139. PubMed ID: 30763298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole Genome Sequencing of Influenza A and B Viruses With the MinION Sequencer in the Clinical Setting: A Pilot Study.
    Imai K; Tamura K; Tanigaki T; Takizawa M; Nakayama E; Taniguchi T; Okamoto M; Nishiyama Y; Tarumoto N; Mitsutake K; Murakami T; Maesaki S; Maeda T
    Front Microbiol; 2018; 9():2748. PubMed ID: 30483243
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic variations of the Hemagglutinin gene of Pandemic Influenza A (H1N1) viruses in Assam, India during 2016.
    Sarmah K; Borkakoty B; Sarma K; Hazarika R; Das PK; Jakharia A; Das M; Biswas D
    3 Biotech; 2018 Oct; 8(10):408. PubMed ID: 30237955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.
    Kumar S; Stecher G; Li M; Knyaz C; Tamura K
    Mol Biol Evol; 2018 Jun; 35(6):1547-1549. PubMed ID: 29722887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Within-Host Evolution of Human Influenza Virus.
    Xue KS; Moncla LH; Bedford T; Bloom JD
    Trends Microbiol; 2018 Sep; 26(9):781-793. PubMed ID: 29534854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.
    Rondy M; Kissling E; Emborg HD; Gherasim A; Pebody R; Trebbien R; Pozo F; Larrauri A; McMenamin J; Valenciano M;
    Euro Surveill; 2018 Mar; 23(9):. PubMed ID: 29510782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.
    Flannery B; Chung JR; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Foust A; Sessions W; Berman L; Barnes JR; Spencer S; Fry AM
    MMWR Morb Mortal Wkly Rep; 2018 Feb; 67(6):180-185. PubMed ID: 29447141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle.
    Cheng AC; Subbarao K
    J Infect Dis; 2018 Jun; 218(2):176-178. PubMed ID: 29361111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.